Want to see DRUG full AI Analyst Report?
Bright Minds Biosciences (DRUG) Ownership Overview
20.93% Insiders
4.37% Mutual Funds
52.81% Other Institutional Investors
4.91% ETFs
16.98% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 62.09% of the company’s stock is owned by Institutional Investors, 20.93% is owned by Insiders, and 16.98% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 05, 2026 | xxxxxxxxxxxxx | C$14095 | |
Oct 01, 2026 | xxxxxxxxxxxxx | C$7152 | |
Jun 13, 2026 | xxxxxxxxxxxxx | $99257 | |
Jun 10, 2026 | xxxxxxxxxxxxx | $425850 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,006,525 | Insider | 10.20% | 50,114,880 | |
| 950,000 | Insider | 9.63% | 47,300,500 | |
| 433,377 | Institution | 4.39% | 21,577,841 | |
| 377,544 | Institution | 3.83% | 18,797,916 | |
| 283,000 | Institution | 2.87% | 14,090,570 | |
| 277,704 | Institution | 2.82% | 13,826,882 | |
| 265,000 | Institution | 2.69% | 13,194,350 | |
| 130,013 | Institution | 1.32% | 6,473,347 | |
| 95,655 | Institution | 0.97% | 4,762,662 | |
| 74,376 | Institution | 0.75% | 3,703,181 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 130,013 | Institution | 1.32% | 6,473,347 | |
| 95,655 | Institution | 0.97% | 4,762,662 | |
| 74,376 | Institution | 0.75% | 3,703,181 | |
| 42,006 | Institution | 0.43% | 2,091,479 | |
| 30,031 | Institution | 0.30% | 1,495,243 | |
| 15,318 | Institution | 0.16% | 762,683 | |
| 8,329 | Institution | 0.08% | 414,701 | |
| 8,063 | Institution | 0.08% | 401,457 | |
| 7,610 | Institution | 0.08% | 378,902 | |
| 5,355 | Institution | 0.05% | 266,625 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 185,596 | Institution | 1.88% | 9,240,825 | |
| 66,787 | Institution | 0.68% | 3,325,325 | |
| 53,587 | Institution | 0.54% | 2,637,016 | |
| 42,551 | Institution | 0.43% | 3,052,183 | |
| 22,165 | Institution | 0.22% | 1,103,595 | |
| 12,702 | Institution | 0.13% | 632,814 | |
| 8,114 | Institution | 0.08% | 582,017 | |
| 5,934 | Institution | 0.06% | 300,794 | |
| 3,870 | Institution | 0.04% | 385,437 | |
| 2,021 | Institution | 0.02% | 100,626 |
FAQ
Who Owns Bright Minds Biosciences (DRUG)?
According to the latest TipRanks data, approximately 52.81% of the company's stock is held by institutional investors, 20.93% is held by insiders, and 16.98% is held by retail investors.
What percentage of Bright Minds Biosciences (DRUG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 52.81% of Bright Minds Biosciences (DRUG) stock is held by institutional investors.
What percentage of Bright Minds Biosciences (DRUG) stock is held by retail investors?
According to the latest TipRanks data, approximately 16.98% of Bright Minds Biosciences (DRUG) stock is held by retail investors.
Who owns the most shares of Bright Minds Biosciences (DRUG)?
Ian Mcdonald owns the most shares of Bright Minds Biosciences (DRUG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.